| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |